Arcutis Biotherapeutics, Inc. Quarterly Costs and Expenses in USD from Q1 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q2 2025.
  • Arcutis Biotherapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2025 was $96.1M, a 18.8% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2025 was $349M, a 12% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2024 was $325M, a 8.06% increase from 2023.
  • Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $301M, a 1.51% decline from 2022.
  • Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2022 was $305M, a 47.8% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $349M $96.1M +$15.2M +18.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $334M $90.4M +$9.18M +11.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $325M $79M +$4.3M +5.75% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $321M $83.8M +$8.81M +11.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $312M $80.9M +$8.98M +12.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 $303M $81.2M +$2.15M +2.71% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $301M $74.7M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $75M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $72M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $79M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.